Should You Buy UnitedHealth Group (UNH) Stock Before October 28?

Key Points

• UnitedHealth is dealing with a government investigation and turnover at the top.

• It’s still the biggest health insurer in the country, with a solid dividend yield.

• See if it inspires confidence, because this could be a good buying opportunity.

• 10 stocks we like better than UnitedHealth Group ›

UnitedHealth Group (NYSE: UNH) is the top dog in health insurance in America, recently with a market value of $313 billion. Its stock is down some 37% over the past year, though, for several reasons, such as its being investigated by the Department of Justice for possible Medicare fraud, and its CEO having stepped down.

With the stock down so much, that means its dividend yield has been pushed up — recently to 2.5%. (Add in stock buybacks, and shareholders have recently been rewarded with a total yield of 5.5%, per Morningstar.com.)

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

Image source: Getty Images.

All this has created a promising buying opportunity for anyone who believes that UnitedHealth will turn its fortunes around over the long haul. If you’re a UnitedHealth bull and are thinking of buying, you might want to do so before Oct. 28, because that’s when the company will release its next earnings report. If the news is good, the stock may pop, though if it disappoints, there may be an even more attractive entry point ahead. (Note that Warren Buffett’s company, Berkshire Hathaway, has been buying shares and recently owned a stake worth nearly $1.6 billion.)

There are certainly reasons to be hopeful. The company is planning to trim costs (in part with the help of artificial intelligence (AI) and to increase premiums in 2026 and 2027. Many investors are feeling better about the company, and its shares have risen close to 16% in the past month. Simple demographics are auspicious, as our growing and aging population will continue to need healthcare — and medications. (UnitedHealth includes the pharmaceutical specialist Optum.)

The stock appears undervalued, as well, with its recent price-to-earnings (P/E) ratio of 15 well below its five-year average of 23.6 and its price-to-sales ratio (PSR) of 0.75 below the five-year average of 1.29. So take a closer look if you find yourself intrigued.

Should you invest $1,000 in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $652,872!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,092,280!*

Now, it’s worth noting Stock Advisor’s total average return is 1,062% — a market-crushing outperformance compared to 189% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of September 29, 2025

Selena Maranjian has positions in Berkshire Hathaway. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.